phenylalanine has been researched along with Migraine Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choudhary, AK; Lee, YY | 1 |
| Ferrari, MD; Frants, RR; MaassenVanDenBrink, A; Mehrotra, S; van den Maagdenberg, AM; Vanmolkot, KR | 1 |
| Marcus, R; Seltzer, S; Stoch, R | 1 |
| Sicuteri, F | 2 |
| Fanchamps, A | 1 |
| Elghozi, JL; Laude, D | 1 |
| Anselmi, B; Fanciullacci, M; Sicuteri, F | 1 |
3 review(s) available for phenylalanine and Migraine Disorders
| Article | Year |
|---|---|
Neurophysiological symptoms and aspartame: What is the connection?
Topics: Affect; Animals; Aspartame; Aspartic Acid; Brain; Cognitive Dysfunction; Disease Models, Animal; Dopamine; Free Radicals; Humans; Hydrocortisone; Migraine Disorders; Nervous System Diseases; Neurotransmitter Agents; Non-Nutritive Sweeteners; Norepinephrine; Oxidative Stress; Phenylalanine; Seizures; Serotonin; Sleep Initiation and Maintenance Disorders | 2018 |
Perspectives in the control of chronic pain by nutritional manipulation.
Topics: Animals; Antidepressive Agents; Brain; Chronic Disease; Humans; Leucine; Migraine Disorders; Neurotransmitter Agents; Pain; Phenylalanine; Rats; Sensory Thresholds; Serotonin; Tryptophan | 1981 |
[Pathogenesis of migraine and mode of action of antimigraine agents].
Topics: Cerebrovascular Circulation; Ergotamine; Histamine; Humans; Methysergide; Migraine Disorders; Norepinephrine; Phenylalanine; Prostaglandins; Serotonin; Tyramine | 1975 |
2 trial(s) available for phenylalanine and Migraine Disorders
| Article | Year |
|---|---|
The phe-124-Cys and A-161T variants of the human 5-HT1B receptor gene are not major determinants of the clinical response to sumatriptan.
Topics: Adult; Aged; Cysteine; DNA Mutational Analysis; Female; Gene Frequency; Genetic Variation; Humans; Male; Middle Aged; Migraine Disorders; Pharmacogenetics; Phenylalanine; Receptor, Serotonin, 5-HT1B; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome | 2007 |
A therapeutic trial in migraine with parachlorophenylalanine, a specific serotonin depletor.
Topics: Chlorine; Clinical Trials as Topic; Female; Humans; Hydroxyindoleacetic Acid; Migraine Disorders; Phenylalanine; Placebos | 1970 |
3 other study(ies) available for phenylalanine and Migraine Disorders
| Article | Year |
|---|---|
Enkephalinase inhibition relieves pain syndromes of central dysnociception (migraine and related headache).
Topics: Acute Disease; Adult; Animals; Aprotinin; Bradykinin; Captopril; Drug Therapy, Combination; Ergotamine; Female; Guinea Pigs; Headache; Humans; Hypertension; Male; Mice; Middle Aged; Migraine Disorders; Neprilysin; Pain; Phenylalanine; Proline; Protease Inhibitors | 1981 |
Hypothesis: migraine, a central biochemical dysnociception.
Topics: Adult; Animals; Apomorphine; Circadian Rhythm; Dopamine; Female; Fever; Headache; Humans; Levodopa; Lysergic Acid Diethylamide; Male; Migraine Disorders; Nervous System; Norepinephrine; Pain; Perceptual Disorders; Phenylalanine; Psilocybin; Rats; Reserpine; Serotonin; Sleep; Somatosensory Cortex; Synaptic Transmission | 1976 |
[5-HIAA: perspectives in nephrology].
Topics: Animals; Carcinoid Tumor; Humans; Hydroxyindoleacetic Acid; Intestinal Mucosa; Kidney; Metabolic Clearance Rate; Migraine Disorders; Nervous System Diseases; p-Aminohippuric Acid; Phenylalanine; Rats; Renal Circulation; Serotonin | 1989 |